HUP0203152A3 - Method and compositions for treating pulmonary diseases - Google Patents

Method and compositions for treating pulmonary diseases

Info

Publication number
HUP0203152A3
HUP0203152A3 HU0203152A HUP0203152A HUP0203152A3 HU P0203152 A3 HUP0203152 A3 HU P0203152A3 HU 0203152 A HU0203152 A HU 0203152A HU P0203152 A HUP0203152 A HU P0203152A HU P0203152 A3 HUP0203152 A3 HU P0203152A3
Authority
HU
Hungary
Prior art keywords
compositions
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Application number
HU0203152A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HUP0203152A2 publication Critical patent/HUP0203152A2/hu
Publication of HUP0203152A3 publication Critical patent/HUP0203152A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0203152A 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases HUP0203152A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (2)

Publication Number Publication Date
HUP0203152A2 HUP0203152A2 (hu) 2003-01-28
HUP0203152A3 true HUP0203152A3 (en) 2004-06-28

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203152A HUP0203152A3 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Country Status (29)

Country Link
EP (1) EP1225866A4 (bg)
JP (1) JP2003513028A (bg)
KR (1) KR20020057988A (bg)
CN (1) CN1387404A (bg)
AP (1) AP2002002496A0 (bg)
AR (1) AR029189A1 (bg)
AU (1) AU1357501A (bg)
BG (1) BG106748A (bg)
BR (1) BR0015270A (bg)
CA (1) CA2388333A1 (bg)
CO (1) CO5261512A1 (bg)
CZ (1) CZ20021512A3 (bg)
DZ (1) DZ3225A1 (bg)
EA (1) EA200200518A1 (bg)
EC (1) ECSP003747A (bg)
HK (1) HK1049107A1 (bg)
HU (1) HUP0203152A3 (bg)
IL (1) IL149367A0 (bg)
MA (1) MA26841A1 (bg)
MX (1) MXPA02004350A (bg)
NO (1) NO20022057L (bg)
OA (1) OA12076A (bg)
PE (1) PE20011005A1 (bg)
PL (1) PL355261A1 (bg)
SK (1) SK7592002A3 (bg)
TR (1) TR200201211T2 (bg)
TW (1) TWI242431B (bg)
WO (1) WO2001032127A2 (bg)
ZA (1) ZA200203435B (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU229442B1 (hu) * 2001-09-19 2013-12-30 Takeda Gmbh Nem-szteroid gyulladásgátlók és PDE4 inhibitorok kombinációi és alkalmazásuk
EP1463509A1 (en) * 2001-10-31 2004-10-06 MERCK PATENT GmbH Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
US20060199789A1 (en) * 2003-03-31 2006-09-07 Kyowa Hakko Kogyo Co., Ltd. medical composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
WO2006041121A1 (ja) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. 慢性皮膚疾患の治療および／または予防剤
RU2008119322A (ru) * 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Композиции ингибиторов фосфодиэстеразы iv типа
EP3431128A1 (en) 2010-01-05 2019-01-23 MicroDose Therapeutx, Inc. Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0710109T1 (en) * 1993-06-18 2005-02-28 Smithkline Beecham Corporation Method for identifying a PDE IV inhibitor
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
HUP0203152A2 (hu) 2003-01-28
DZ3225A1 (fr) 2001-05-10
NO20022057L (no) 2002-06-27
EP1225866A2 (en) 2002-07-31
HK1049107A1 (zh) 2003-05-02
MXPA02004350A (es) 2002-11-07
CO5261512A1 (es) 2003-03-31
EA200200518A1 (ru) 2002-10-31
CN1387404A (zh) 2002-12-25
KR20020057988A (ko) 2002-07-12
BR0015270A (pt) 2002-06-18
TR200201211T2 (tr) 2002-08-21
WO2001032127A2 (en) 2001-05-10
PL355261A1 (en) 2004-04-05
AU1357501A (en) 2001-05-14
PE20011005A1 (es) 2001-09-28
OA12076A (en) 2006-05-04
SK7592002A3 (en) 2002-11-06
BG106748A (bg) 2003-02-28
IL149367A0 (en) 2002-11-10
TWI242431B (en) 2005-11-01
NO20022057D0 (no) 2002-04-30
JP2003513028A (ja) 2003-04-08
CA2388333A1 (en) 2001-05-10
MA26841A1 (fr) 2004-12-20
AP2002002496A0 (en) 2002-06-30
ZA200203435B (en) 2003-06-25
AR029189A1 (es) 2003-06-18
ECSP003747A (es) 2002-05-23
CZ20021512A3 (cs) 2003-04-16
WO2001032127A3 (en) 2001-12-06
EP1225866A4 (en) 2004-04-21

Similar Documents

Publication Publication Date Title
IL142132A0 (en) Methods and compositions for treating receptor mediated diseases
EP1416961A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF A DISEASE
HK1048949A1 (en) Method and composition for the treatment of scars
AU2002219945A1 (en) Composition and method for treating snoring
HU0001471D0 (en) New method of treatment
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
EP1109548A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING BONE DISEASES USING TOCOTRIENOLE
AU2002367023A8 (en) Compositions and methods for treating heart failure
HU0001629D0 (en) Method for treating plants and compositions for it
AU2002365057A8 (en) Compositions and methods for treating heart failure
HUP0203152A3 (en) Method and compositions for treating pulmonary diseases
IL150963A0 (en) Method and compositions for treating an inflammatory disease
EP1234869A4 (en) CLEANING COMPOSITION AND METHOD FOR PRODUCING THE SAME
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
AU6137801A (en) Method and composition for the treatment of angiogenesis
EP1261331A4 (en) METHOD AND COMPOSITIONS FOR TREATING FIBROSANT DISEASES
HUP0101326A3 (en) Paroxetine compositions and process for their preparation
EP1349548A4 (en) METHOD AND COMPOSITIONS FOR TREATING PERIODONTOSIS
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
IL138654A0 (en) Methods and materials for treating inflammatory diseases
EP1173159A4 (en) COMPOSITION AND METHOD FOR TREATING COLIC
EP1397507A4 (en) METHOD AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE WITH 10218
GB0024961D0 (en) Compositions and methods for treating respiratory disease
GB9917409D0 (en) Composition and method
GB9929493D0 (en) Composition and method